<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/css" href="http://www.antibodies-online.com/rss.css" ?><rss version="2.0"><channel><docs>http://blogs.law.harvard.edu/tech/rss</docs><title>antibodies-online.com | News | Research News</title><category>Research News</category><link>http://www.antibodies-online.com/news/3/Research+News/</link><description>Research News</description><language>en</language><copyright>2005-2008 antibodies-online GmbH</copyright><generator>antibodies-online GmbH RSS Feed</generator><webMaster>news@antikoerper-online.de (Alexander Golubowitsch)</webMaster><managingEditor>news@antikoerper-online.de (Tim Hiddemann)</managingEditor><lastBuildDate>Mon, 08 Jun 2009 18:55:00 +0200</lastBuildDate><pubDate>Thu, 11 Mar 2010 16:19:12 +0100</pubDate><ttl>720</ttl><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 08 Jun 2009 18:55:00 +0200</pubDate><title>Ankyrin Repeat Proteins Comprise a Diverse Family of Bacterial Type IV Effectors</title><category>Research News</category><description>The intracellular pathogens &lt;a href=&quot;http://www.antibodies-online.com/antigen/Legionella+pneumophila/&quot;&gt;&lt;em&gt;Legionella pneumophila&lt;/em&gt;&lt;/a&gt; and &lt;em&gt;Coxiella burnetii&lt;/em&gt; use a type IV secretion system to deliver a large number of different &lt;a href=&quot;http://www.antibodies-online.com/research-area/Bacteria/&quot;&gt;bacterial&lt;/a&gt; proteins with Anks (&lt;a href=&quot;http://www.antibodies-online.com/antigen/A/3/&quot;&gt;ankyrin repeat homology domains&lt;/a&gt;) into eukaryotic cells.</description><link>http://www.antibodies-online.com/news/3/504/Ankyrin+Repeat+Proteins+Comprise+a+Diverse+Family+of+Bacterial+Type+IV+Effectors/</link><guid>http://www.antibodies-online.com/news/3/504/Ankyrin+Repeat+Proteins+Comprise+a+Diverse+Family+of+Bacterial+Type+IV+Effectors/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 08 Jun 2009 18:53:00 +0200</pubDate><title>Conformational Switch of Syntaxin-1 Controls Synaptic Vesicle Fusion</title><category>Research News</category><description>The SNARE protein &lt;a href=&quot;http://www.antibodies-online.com/antigen/Syntaxin+1/&quot;&gt;syntaxin-1&lt;/a&gt; exists in two conformations during synaptic vesicle fusion, both of which can bind to &lt;a href=&quot;http://www.antibodies-online.com/antigen/Munc+18/&quot;&gt;Munc18&lt;/a&gt;-1: the &quot;open&quot; conformation in the SNARE complex and a &quot;closed&quot; conformation outside the SNARE complex.</description><link>http://www.antibodies-online.com/news/3/503/Conformational+Switch+of+Syntaxin-1+Controls+Synaptic+Vesicle+Fusion/</link><guid>http://www.antibodies-online.com/news/3/503/Conformational+Switch+of+Syntaxin-1+Controls+Synaptic+Vesicle+Fusion/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 08 Jun 2009 18:50:00 +0200</pubDate><title>Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs</title><category>Research News</category><description>A research group from the University of Iowa (USA) generated pigs in which both &lt;a href=&quot;http://www.antibodies-online.com/antigen/CFTR/&quot;&gt;CFTR&lt;/a&gt; alleles were disrupted. Two decades ago &lt;a href=&quot;http://www.antibodies-online.com/antigen/CFTR/&quot;&gt;CFTR&lt;/a&gt; was identified as the gene causing cystic fibrosis, however a cure to the disease has not been established yet.</description><link>http://www.antibodies-online.com/news/3/502/Disruption+of+the+CFTR+Gene+Produces+a+Model+of+Cystic+Fibrosis+in+Newborn+Pigs/</link><guid>http://www.antibodies-online.com/news/3/502/Disruption+of+the+CFTR+Gene+Produces+a+Model+of+Cystic+Fibrosis+in+Newborn+Pigs/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Fri, 08 May 2009 13:06:00 +0200</pubDate><title>An alternative Menaquinone Biosynthetic Pathway Operating in Microorganisms</title><category>Research News</category><description>A Japanese research team from the Biotechnology Research Center in Toyama performed a bioinformatic analysis of whole genome sequences in order to find orthologues of the men genes in &lt;a href=&quot;http://www.antibodies-online.com/antigen/Escherichia+Coli/&quot;&gt;&lt;em&gt;Escherichia coli&lt;/em&gt;&lt;/a&gt;. The men genes enable microorganisms to synthesise menaquinone (vitamin K2), an essential component of the electron-transfer pathway. In &lt;a href=&quot;http://www.antibodies-online.com/antigen/Escherichia+Coli/&quot;&gt;&lt;em&gt;E. coli&lt;/em&gt;&lt;/a&gt; it is derived from chorismate by seven enzymes.</description><link>http://www.antibodies-online.com/news/3/491/An+alternative+Menaquinone+Biosynthetic+Pathway+Operating+in+Microorganisms/</link><guid>http://www.antibodies-online.com/news/3/491/An+alternative+Menaquinone+Biosynthetic+Pathway+Operating+in+Microorganisms/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Tue, 03 Mar 2009 09:38:00 +0100</pubDate><title>An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity</title><category>Research News</category><description>The essential bacterial guanosine triphosphatase &lt;a href=&quot;http://www.antibodies-online.com/antibody/190734/anti-Procaryotic+Cell+Division+Gtpase+Ftsz/&quot;&gt;FtsZ&lt;/a&gt; was validated as a target for antibacterial intervention by British researchers from Prolysis in Oxfordshire and the University of Sheffield. &lt;a href=&quot;http://www.antibodies-online.com/antibody/190734/anti-Procaryotic+Cell+Division+Gtpase+Ftsz/&quot;&gt;FtsZ&lt;/a&gt; is a bacterial homologue of mammalian β-tubulin that initiates cell division by polymerising and then assembling into a ring.</description><link>http://www.antibodies-online.com/news/3/466/An+Inhibitor+of+FtsZ+with+Potent+and+Selective+Anti-Staphylococcal+Activity/</link><guid>http://www.antibodies-online.com/news/3/466/An+Inhibitor+of+FtsZ+with+Potent+and+Selective+Anti-Staphylococcal+Activity/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Tue, 03 Mar 2009 09:35:00 +0100</pubDate><title>Molecular Coupling of Xist Regulation and Pluripotency</title><category>Research News</category><description>Pluripotency key factors bind to Xist intron 1 in undifferentiated embryonic stem cells, report research groups from the Pasteur Institute in Paris and the University of Edinburgh, UK. During murine embryogenesis, the imprinted &lt;a href=&quot;http://www.antibodies-online.com/antibody/170084/chromosome+X+open+reading+frame+2+CXorf2+Human/&quot;&gt;X chromosome&lt;/a&gt; inactivation can be reprogrammed in the inner cell mass of a pluripotent female blastocyst. The reversion is triggered by repression of Xist from the paternal &lt;a href=&quot;http://www.antibodies-online.com/antibody/170084/chromosome+X+open+reading+frame+2+CXorf2+Human/&quot;&gt;X chromosome&lt;/a&gt;. The three main genetic factors underlying pluripotency, &lt;a href=&quot;http://www.antibodies-online.com/antigen/Nanog+Homeobox+%28NANOG%29/&quot;&gt;Nanog&lt;/a&gt;, &lt;a href=&quot;http://www.antibodies-online.com/antigen/Organic+Cation+Transporter+3+%28OCT3%29/&quot;&gt;Oct3&lt;/a&gt;/&lt;a href=&quot;http://www.antibodies-online.com/antibody/223270/anti-Oct-4/&quot;&gt;4&lt;/a&gt; and &lt;a href=&quot;http://www.antibodies-online.com/antigen/SOX2/&quot;&gt;Sox2&lt;/a&gt;, bind to Xist intron 1.</description><link>http://www.antibodies-online.com/news/3/465/Molecular+Coupling+of+Xist+Regulation+and+Pluripotency/</link><guid>http://www.antibodies-online.com/news/3/465/Molecular+Coupling+of+Xist+Regulation+and+Pluripotency/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Tue, 03 Mar 2009 09:31:00 +0100</pubDate><title>FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression</title><category>Research News</category><description>The &lt;a href=&quot;http://www.antibodies-online.com/research-area/Enzymes/&quot;&gt;enzyme&lt;/a&gt; &lt;a href=&quot;http://www.antibodies-online.com/antigen/mTOR/&quot;&gt;mTOR&lt;/a&gt; (&lt;a href=&quot;http://www.antibodies-online.com/antigen/mTOR/&quot;&gt;mammalian target of rapamycin&lt;/a&gt;) is selected for ubiquitination and subsequent degradation by binding to the tumour suppressor protein FBXW7</description><link>http://www.antibodies-online.com/news/3/464/FBXW7+Targets+mTOR+for+Degradation+and+Cooperates+with+PTEN+in+Tumor+Suppression/</link><guid>http://www.antibodies-online.com/news/3/464/FBXW7+Targets+mTOR+for+Degradation+and+Cooperates+with+PTEN+in+Tumor+Suppression/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Thu, 12 Feb 2009 20:15:00 +0100</pubDate><title>Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart</title><category>Research News</category><description>Mitochondrial aldehyde dehydrogenase 2 (ALDH2) was identified as an &lt;a href=&quot;http://www.antibodies-online.com/research-area/Enzymes/&quot;&gt;enzyme&lt;/a&gt; whose activation correlates with reduced ischemic heart damage in rodent models by Che-Hong Chen and colleagues from the Stanford University (USA), using an unbiased proteomic search. The research team wanted to find a &lt;a href=&quot;http://www.antibodies-online.com/research-area/Drugs/&quot;&gt;drug&lt;/a&gt; that limits the severity of ischemia-induced cardiac damage occurring after a myocardial infarction or certain cardiac surgical procedures.</description><link>http://www.antibodies-online.com/news/3/414/Activation+of+Aldehyde+Dehydrogenase-2+Reduces+Ischemic+Damage+to+the+Heart/</link><guid>http://www.antibodies-online.com/news/3/414/Activation+of+Aldehyde+Dehydrogenase-2+Reduces+Ischemic+Damage+to+the+Heart/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Thu, 12 Feb 2009 20:11:00 +0100</pubDate><title>Epigenetic Reprogramming by Adenovirus E1A</title><category>Research News</category><description>Epigenetic reprogramming by &lt;a href=&quot;http://www.antibodies-online.com/antibody/187759/anti-Adenovirus+E1A/&quot;&gt;Adenovirus E1A&lt;/a&gt; that causes transformations of the cell were discovered by Roberto Ferrari and his co-workers from the University of California (USA).</description><link>http://www.antibodies-online.com/news/3/413/Epigenetic+Reprogramming+by+Adenovirus+E1A/</link><guid>http://www.antibodies-online.com/news/3/413/Epigenetic+Reprogramming+by+Adenovirus+E1A/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Tue, 03 Feb 2009 13:31:00 +0100</pubDate><title>Censoring of Autoreactive B Cell Development by the Pre-B Cell Receptor</title><category>Research News</category><description>&lt;p&gt;The &lt;a href=&quot;http://www.antibodies-online.com/antibody/139832/anti-Pre+B+Cell/&quot;&gt;pre-B cell&lt;/a&gt; receptor appears to censor the development of certain autoantibody-secreting cells, as Rebecca A. Keenan and her team from The Babraham Institute in Cambridge, UK report. The &lt;a href=&quot;http://www.antibodies-online.com/antibody/139832/anti-Pre+B+Cell/&quot;&gt;pre-B cell&lt;/a&gt; receptor is composed of immunoglobulin (Ig) heavy and substitute light chains. It seems to be involved in the negative selection of cells expressing heavy chains bearing the potential to generate autoantibodies. It thus may be an important factor in multifactorial autoimmune diseases.</description><link>http://www.antibodies-online.com/news/3/401/Censoring+of+Autoreactive+B+Cell+Development+by+the+Pre-B+Cell+Receptor/</link><guid>http://www.antibodies-online.com/news/3/401/Censoring+of+Autoreactive+B+Cell+Development+by+the+Pre-B+Cell+Receptor/</guid></item><item><author>news@antikoerper-online.de (Tim Hiddemann)</author><pubDate>Wed, 21 Jan 2009 19:16:00 +0100</pubDate><title>New publication: Detection of Bacteria in water samples</title><category>Research News</category><description>Anne Wolter et al. utilize a &lt;a href=&quot;http://www.antibodies-online.com/antibody/98958/anti-Escherichia+coli/&quot;&gt;polyclonal anti-E. Coli antibody&lt;/a&gt; from antibodies-online for detecting E. Coli bacteria in water. </description><guid>http://www.antibodies-online.com/news/3/398/New+publication+Detection+of+Bacteria+in+water+samples/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 12 Jan 2009 11:29:00 +0100</pubDate><title>Pyogenic Bacterial Infections in Humans with MyD88 Deficiency</title><category>Research News</category><description>Scientists from mainly French and Spanish universities and institutes recently described an extraordinary situation within a natural setting of human infection. Nine children, carrying an autosomal recessive &lt;a href=&quot;http://www.antibodies-online.com/antigen/MyD88/&quot;&gt;MyD88&lt;/a&gt; deficiency, suffered from pyogenic bacterial infections. The infections were life-threatening and often recurred, among them invasive pneumococcal disease.</description><link>http://www.antibodies-online.com/news/3/396/Pyogenic+Bacterial+Infections+in+Humans+with+MyD88+Deficiency/</link><guid>http://www.antibodies-online.com/news/3/396/Pyogenic+Bacterial+Infections+in+Humans+with+MyD88+Deficiency/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 12 Jan 2009 11:28:00 +0100</pubDate><title>Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition</title><category>Research News</category><description>Excessive &lt;a href=&quot;http://www.antibodies-online.com/antigen/Serotonin/&quot;&gt;serotonin&lt;/a&gt; autoinhibition was found to be a risk factor for autonomic dysregulation by Enrica Audero and her colleagues from the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy. It could also be a mechanism by which altered &lt;a href=&quot;http://www.antibodies-online.com/antigen/Serotonin/&quot;&gt;serotonin&lt;/a&gt; homeostasis plays a role in sudden infant death syndrome.</description><link>http://www.antibodies-online.com/news/3/395/Sporadic+Autonomic+Dysregulation+and+Death+Associated+with+Excessive+Serotonin+Autoinhibition/</link><guid>http://www.antibodies-online.com/news/3/395/Sporadic+Autonomic+Dysregulation+and+Death+Associated+with+Excessive+Serotonin+Autoinhibition/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Mon, 12 Jan 2009 11:26:00 +0100</pubDate><title>Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer</title><category>Research News</category><description>Germline allele-specific expression of the gene encoding &lt;a href=&quot;http://www.antibodies-online.com/antigen/TGF-beta+Receptor+I/&quot;&gt;TGF-β type I receptor&lt;/a&gt; (&lt;a href=&quot;http://www.antibodies-online.com/antigen/TGF-beta+Receptor+I/&quot;&gt;TGFBR1&lt;/a&gt;) occurs more frequently in colorectal cancer patients than in healthy controls. This was shown in a study by Laura Valle and her colleagues from The Ohio State University (USA).</description><link>http://www.antibodies-online.com/news/3/394/Germline+Allele-Specific+Expression+of+TGFBR1+Confers+an+Increased+Risk+of+Colorectal+Cancer/</link><guid>http://www.antibodies-online.com/news/3/394/Germline+Allele-Specific+Expression+of+TGFBR1+Confers+an+Increased+Risk+of+Colorectal+Cancer/</guid></item><item><author>news@antikoerper-online.de (Anna Lena Marwedel)</author><pubDate>Thu, 04 Dec 2008 10:48:00 +0100</pubDate><title>Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2</title><category>Research News</category><description>Researchers of the National Cancer Institute (USA) recently reported the establishment of a simple, versatile and reliable assay to test for the functional significance of mutations in the &lt;a href=&quot;http://www.antibodies-online.com/antigen/BRCA2/&quot;&gt;BRCA2&lt;/a&gt; gene. Humans carrying mutations in the genes &lt;a href=&quot;http://www.antibodies-online.com/antigen/BRCA1/&quot;&gt;BRCA1&lt;/a&gt; and &lt;a href=&quot;http://www.antibodies-online.com/antigen/BRCA2/&quot;&gt;BRCA2&lt;/a&gt; have a risk of 80% to develop breast cancer by the age of 70. Reliable identification of mutation carriers can reduce mortality through preventive measures and early diagnosis. The tests available until now could only detect &lt;a href=&quot;http://www.antibodies-online.com/antigen/BRCA1/&quot;&gt;BRCA1&lt;/a&gt; and &lt;a href=&quot;http://www.antibodies-online.com/antigen/BRCA2/&quot;&gt;BRCA2&lt;/a&gt; variants that clearly disrupt the gene product.</description><link>http://www.antibodies-online.com/news/3/384/Mouse+embryonic+stem+cellbased+functional+assay+to+evaluate+mutations+in+BRCA2/</link><guid>http://www.antibodies-online.com/news/3/384/Mouse+embryonic+stem+cellbased+functional+assay+to+evaluate+mutations+in+BRCA2/</guid></item></channel></rss>